Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjib Basu

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
The Annals of Thoracic Surgery|September 28, 2011
Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancerDavid D Shersher, Michael S Vercillo, Cristina Fhied, et al.
Journal of General Internal Medicine|March 9, 2022
Pragmatic Clinical Trial to Improve Patient Experience Among Adults During Transitions from Hospital to Home: the PArTNER studyStephanie L LaBedz, Valentin Prieto-Centurion, Amelia Mutso, et al.
The Annals of Thoracic Surgery|October 11, 2014
Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinomaShaun Daly, John C Kubasiak, Daniel Rinewalt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 4, 2012
Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodulesShaun Daly, Daniel Rinewalt, Cristina Fhied, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinibLela E Buckingham, John S Coon, Larry E Morrison, et al.
Oncotarget|September 24, 2017
Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapyMary Jo Fidler, Casey Frankenberger, Richard Seto, et al.
Lung Cancer (Amsterdam, Netherlands)|June 24, 2010
Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancerAnthony W Kim, Marta Batus, Ronald Myint, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 15, 2014
Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancerJohn C Kubasiak, Christopher W Seder, Ravi Pithadia, et al.
Annals of the American Thoracic Society|September 8, 2023
A Hybrid Effectiveness/Implementation Clinical Trial of Adherence to Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary DiseaseValentin Prieto-Centurion, Kristen E Holm, Richard Casaburi, et al.
Cancers|May 16, 2023
Development of a Novel Circulating Autoantibody Biomarker Panel for the Identification of Patients with 'Actionable' Pulmonary NodulesClaire Auger, Hita Moudgalya, Matthew R Neely, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
The Annals of Thoracic Surgery|September 28, 2011
Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancerDavid D Shersher, Michael S Vercillo, Cristina Fhied, et al.
Journal of General Internal Medicine|March 9, 2022
Pragmatic Clinical Trial to Improve Patient Experience Among Adults During Transitions from Hospital to Home: the PArTNER studyStephanie L LaBedz, Valentin Prieto-Centurion, Amelia Mutso, et al.
The Annals of Thoracic Surgery|October 11, 2014
Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinomaShaun Daly, John C Kubasiak, Daniel Rinewalt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 4, 2012
Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodulesShaun Daly, Daniel Rinewalt, Cristina Fhied, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinibLela E Buckingham, John S Coon, Larry E Morrison, et al.
Oncotarget|September 24, 2017
Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapyMary Jo Fidler, Casey Frankenberger, Richard Seto, et al.
Lung Cancer (Amsterdam, Netherlands)|June 24, 2010
Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancerAnthony W Kim, Marta Batus, Ronald Myint, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 15, 2014
Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancerJohn C Kubasiak, Christopher W Seder, Ravi Pithadia, et al.
Annals of the American Thoracic Society|September 8, 2023
A Hybrid Effectiveness/Implementation Clinical Trial of Adherence to Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary DiseaseValentin Prieto-Centurion, Kristen E Holm, Richard Casaburi, et al.
Cancers|May 16, 2023
Development of a Novel Circulating Autoantibody Biomarker Panel for the Identification of Patients with 'Actionable' Pulmonary NodulesClaire Auger, Hita Moudgalya, Matthew R Neely, et al.
Pageof 11